AI MARKET SCANNING

Sarepta Therapeutics, Inc.

🏛️ NASDAQ 📁 Healthcare 🏭 Biotechnology
AVG HISTORICAL GAP -2.07%
MAX GAP RECORD -37.67%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $SRPT
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Aug 05, 2026 Earnings Release 2026-08-05 (AFTER CLOSE)
+4.58%
May 06, 2026 Earnings Release 2026-05-06 (AFTER CLOSE)
-3.34%
Feb 25, 2026 Earnings Release 2026-02-25 (AFTER CLOSE)
-6.17%
Nov 03, 2025 Earnings Release 2025-11-03 (AFTER CLOSE)
-37.67%
Aug 06, 2025 Earnings Release 2025-08-06 (AFTER CLOSE)
+12.24%
May 06, 2025 Earnings Release 2025-05-06 (AFTER CLOSE)
-14.46%
Feb 26, 2025 Earnings Release 2025-02-26 (AFTER CLOSE)
-5.48%
Nov 06, 2024 Earnings Release 2024-11-06 (AFTER CLOSE)
+3.46%

VOLATILITY & GAP BIAS

AVG GAP MOVE 7.8%
Bullish Gaps (6)
Bearish Gaps (7)
Neutral / Flat (2)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $SRPT

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗